Cargando…

Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization

Circulating tumor cells (CTC) isolated from the peripheral blood of cancer patients by a minimally invasive procedure provide surrogate markers of the tumor that can be repeatedly sampled. However, the selection and enumeration of CTCs by traditional methods based on surface proteins like EPCAM may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Evan N., Jayachandran, Gitanjali, Hardy, Max R., Venkata Subramanian, Ananya M., Meng, Xiangtian, Reuben, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584183/ https://www.ncbi.nlm.nih.gov/pubmed/33095819 http://dx.doi.org/10.1371/journal.pone.0241123

Ejemplares similares

Enumeration and molecular characterization of circulating tumor cells enriched by microcavity array from stage III non-small cell lung cancer patients
por: Cohen, Evan N., et al.
Publicado: (2020)

Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens
por: Mattsson, Jenny, et al.
Publicado: (2023)

Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Development and clinical validation of a microfluidic-based platform for CTC enrichment and downstream molecular analysis
por: Cai, Songhua, et al.
Publicado: (2023)

The Bacillus Agnostic
Publicado: (1911)

Microfluidic enrichment for the single cell analysis of circulating tumor cells
por: Yeo, Trifanny, et al.
Publicado: (2016)

Agnostic Tendency in Doctors
Publicado: (1885)

Automated Microfluidic Blood Lysis Protocol for Enrichment of Circulating Nucleated Cells
por: White, William N., et al.
Publicado: (2009)

Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors
por: Borchmann, Sven, et al.
Publicado: (2022)

Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients
por: Cohen, Evan N., et al.
Publicado: (2023)

Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
por: Kulasinghe, Arutha, et al.
Publicado: (2017)

Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients
por: Sajdik, Constantin, et al.
Publicado: (2022)

Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer
por: Cohen, Evan N., et al.
Publicado: (2023)

Tumour-agnostic drugs in paediatric cancers
por: Chisholm, Julia C., et al.
Publicado: (2020)

Drug Development in Tissue-Agnostic Indications
por: du Rusquec, Pauline, et al.
Publicado: (2021)

Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells
por: Mishra, Avanish, et al.
Publicado: (2020)

On‐chip microfluidic buffer swap of biological samples in‐line with downstream dielectrophoresis
por: Huang, Xuhai, et al.
Publicado: (2022)

Source-Agnostic Gravitational-Wave Detection with Transformers
por: Debru, Natnael Berhane
Publicado: (2022)

Polarization- and wavelength-agnostic nanophotonic beam splitter
por: González-Andrade, David, et al.
Publicado: (2019)

Reference-agnostic representation and visualization of pan-genomes
por: Liang, Qihua, et al.
Publicado: (2021)

Technology agnostic frequency characterization methodology for memristors
por: Manouras, Vasileios, et al.
Publicado: (2021)

Model agnostic generation of counterfactual explanations for molecules
por: Wellawatte, Geemi P., et al.
Publicado: (2022)

Crop Agnostic Monitoring Driven by Deep Learning
por: Halstead, Michael, et al.
Publicado: (2021)

Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel
por: Kisistók, Judit, et al.
Publicado: (2023)

New Physics Agnostic Selections For New Physics Searches
por: Woźniak, Kinga Anna, et al.
Publicado: (2020)

A Method for Variant Agnostic Detection of SARS-CoV-2, Rapid Monitoring of Circulating Variants, and Early Detection of Emergent Variants Such as Omicron
por: Lai, Eric, et al.
Publicado: (2022)

Microfluidic droplet enrichment for targeted sequencing
por: Eastburn, Dennis J., et al.
Publicado: (2015)

Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells
por: Khoo, Bee Luan, et al.
Publicado: (2014)

Integrated Microfluidic Device for Enrichment and Identification of Circulating Tumor Cells from the Blood of Patients with Colorectal Cancer
por: Su, Wentao, et al.
Publicado: (2019)

Design and Fabrication of a Novel Microfluidic System for Enrichment of Circulating Tumor Cells with the Assistance of Computer Simulations
por: Dorrigiv, Dina, et al.
Publicado: (2019)

Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood
por: Rodríguez‐Pena, Alejandro, et al.
Publicado: (2022)

Analytical Validation of a Spiral Microfluidic Chip with Hydrofoil-Shaped Pillars for the Enrichment of Circulating Tumor Cells
por: Sen-Dogan, Begum, et al.
Publicado: (2023)

Label-free enrichment of rare unconventional circulating neoplastic cells using a microfluidic dielectrophoretic sorting device
por: Montoya Mira, Jose, et al.
Publicado: (2021)

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix(®) PC1 System
por: Cohen, Evan N., et al.
Publicado: (2022)

NeuralDock: Rapid and Conformation-Agnostic Docking of Small Molecules
por: Sha, Congzhou M., et al.
Publicado: (2022)

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
por: Chan, Hiu Ting, et al.
Publicado: (2023)

Source-Agnostic Gravitational-Wave Detection with Recurrent Autoencoders
por: Moreno, Eric A., et al.
Publicado: (2021)

Agnostic evaluation of ipilimumab and nivolumab association: a metanalysis
por: Marchetti, Paolo, et al.
Publicado: (2020)

TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs
por: Han, Sun-Young
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0f39j6blrm698kh9qkl50k26ic